KKR & Co. is exploring options including selling its controlling stake in India’s JB Chemicals & Pharmaceuticals Ltd. amid interest from potential buyers, according to people familiar with the matter.
The US private equity firm is looking to hire financial advisers to help evaluate a sale of its 53.8% stake in the Mumbai-based company, the people said, asking not to be identified as the matter is private. Other buyout firms and industry players have shown preliminary interest in buying KKR’s stake, the people said.
Shares of the company, which is known as JB Pharma, have climbed 68% in the past 12 months, valuing the firm at just over $3 billion.
Can’t stop reading? Read more
Main Capital targets $5bn fundraise and continuation vehicle growth amid renewed LP appetite
Main Capital targets $5bn fundraise and continuation vehicle growth amid renewed LP appetite Main...
Blackstone taps private credit market for £1.1bn Clarion dividend recap
Blackstone taps private credit market for £1.1bn Clarion dividend recap Blackstone’s Clarion...
Apollo- and Vistria-backed University of Phoenix owner jumps 19% in $1.35bn NYSE debut
Apollo- and Vistria-backed University of Phoenix owner jumps 19% in $1.35bn NYSE debut Phoenix...